DexCom
DXCM
YETI Holdings
YETI
New Fortress Energy
NFE
Dorian LPG
LPG
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
RBOT Vicarious Surgical
- 8.000
- -0.100-1.23%
Close Mar 20 16:00 ET
- 7.700
- -0.300-3.75%
Pre 06:16 ET
47.44MMarket Cap-0.74P/E (TTM)
8.214High7.790Low12.87KVolume8.060Open8.100Pre Close103.06KTurnover0.35%Turnover RatioLossP/E (Static)5.93MShares19.00052wk High1.02P/B29.88MFloat Cap4.27052wk Low--Dividend TTM3.73MShs Float473.565Historical High--Div YieldTTM5.23%Amplitude4.270Historical Low8.009Avg Price1Lot Size
Vicarious Surgical News
Vicarious Surgical Non-GAAP EPS of -$2.43 Beats by $0.05
NVIDIA GTC - A New Era of Generalist Robotics
Vicarious Surgical's Earnings Call: Achievements and Challenges
TD Cowen Maintains Vicarious Surgical(RBOT.US) With Buy Rating, Maintains Target Price $13
BTIG Maintains Vicarious Surgical(RBOT.US) With Hold Rating
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $8.5
Vicarious Surgical Analyst Ratings
Piper Sandler Remains a Hold on Vicarious Surgical (RBOT)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vicarious Surgical (RBOT), Alkermes (ALKS) and Zealand Pharma (OtherZLDPF)
Vicarious Surgical Reports 2024 Financial Results and Progress
Vicarious Surgical's Promising Progress: Buy Rating Affirmed Amid Strategic Milestones and Clinical Advancements
Vicarious Surgical Inc. (RBOT) Q4 2024 Earnings Call Transcript Summary
Vicarious Surgical | 10-K: FY2024 Annual Report
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Vicarious Surgical | 8-K: Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results
Express News | Vicarious Surgical Q4 2024 Adj. EPS $(2.43) Beats $(2.69) Estimate
Vicarious Surgical 4Q Loss/Shr $2.36 >RBOT
Express News | Vicarious Surgical Inc - Sets 2025 Cash Burn Guidance of $50 Million
Earnings Scheduled For March 17, 2025
Vicarious Surgical: Romano Appointment Effective April 1 >RBOT
